Targeting CD39 with a first-in-class inhibitory antibody prevents ATP processing and increases T-cell activation

被引：3
|
作者：
Lerner, Alana G. [1 ]
Kovalenko, Maria [1 ]
Welch, Megan [1 ]
Dela Cruz, Tracy [1 ]
Jones, Jeff [1 ]
Wong, Clifford [1 ]
Spatola, Bradley [1 ]
Eberhardt, Meghan [1 ]
Wong, Andrew [1 ]
Fung, Wanchi [1 ]
Lagpacan, Leanna [1 ]
Losenkova, Karolina [2 ]
Yegutkin, Gennady [2 ]
Soros, Vanessa [1 ]
Corbin, John [1 ]
Beers, Courtney [1 ]
Moesta, Achim K. [1 ]
机构：
[1] Tizona Therapeut, San Francisco, CA USA
[2] Univ Turku, MediCity Res Lab, Turku, Finland
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-5012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5012
引用
收藏
页数：2
相关论文
共 50 条
  • [31] IL-12 AND IL-27 UPREGULATE CD39 EXPRESSION ON CD8+ T-CELLS AND DIFFERENTIALLY AFFECT CD39+CD8+ T-CELL EFFECTOR FUNCTION
    Gerhardt, Lara
    Figueredo, Rene
    Maleki, Saman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1070 - A1070
  • [32] BP1223, a Novel T Cell Engager Targeting CD39 for Potent Antitumor Activity in Acute Myeloid Leukemia
    Yuda, Junichiro
    Aramaki, Takahiko
    Matsumura, Haruka
    Nakajima, Kanto
    Mie, Motoya
    BLOOD, 2024, 144 : 4146 - 4147
  • [33] IL-7 Modulates In Vitro and In Vivo Human Memory T Regulatory Cell Functions through the CD39/ATP Axis
    Younas, Mehwish
    Hue, Sophie
    Lacabaratz, Christine
    Guguin, Aurelie
    Wiedemann, Aurelie
    Surenaud, Mathieu
    Beq, Stephanie
    Croughs, Therese
    Lelievre, Jean-Daniel
    Levy, Yves
    JOURNAL OF IMMUNOLOGY, 2013, 191 (06): : 3161 - 3168
  • [34] TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY
    Middendorp, S.
    Drent, E.
    Bisso, A.
    Baardman, S.
    Verweij, D.
    Salcedo, E.
    Coomans, C.
    Braem, S.
    van de Weg, S.
    Meijer, M.
    Proost, N.
    van de Ven, M.
    Norell, H.
    van Loenen, M.
    Emami, N.
    Melief, S.
    Gobessi, S.
    Throsby, M.
    CYTOTHERAPY, 2023, 25 (06) : S240 - S240
  • [35] TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS gdTCR-BASED T CELL THERAPY
    Drent, Esther
    Middendorp, Sabine
    Bisso, Andrea
    Baardman, Sjoerd
    Verweij, Dagmar
    Salcedo, Estefania
    Coomans, Chris
    Braem, Steven
    van de Weg, Sander
    Meijer, Menno
    Proost, Natalie
    van de Ven, Marieke
    Norell, Haakan
    van Loenen, Marleen
    Emami, Nia
    Melief, Sara
    Gobessi, Stefania
    Throsby, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A229 - A229
  • [36] Assessment of CD39 expression in regulatory T-cell subsets by disease severity in adult and juvenile COVID-19 cases
    Simsek, Abdurrahman
    Kizmaz, Muhammed A.
    Cagan, Eren
    Dombaz, Fatma
    Tezcan, Gulcin
    Asan, Ali
    Demir, H. Ibrahim
    Bal, S. Haldun
    Ermis, Digdem Y.
    Dilektasli, Asli G.
    Kazak, Esra
    Akalin, E. Halis
    Oral, H. Barbaros
    Budak, Ferah
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 2089 - 2101
  • [37] Dual metastasis- and tumor-inhibitory efficacy of a first-in-class metastasis-initiating-cell-targeted therapeutic antibody
    Tsai, K. K. C.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S61 - S61
  • [38] A Novel T-cell Population Expressing the Ectoenzymes CD38 and CD39 is Associated with Melanoma Patient Non-Response to Immunotherapy.
    Mitra, Ankita
    Woods, David M.
    Rao, Anjali
    Laino, Andressa S.
    Winters, Aidan
    Yanai, Itai
    Chattopadhyay, Pratip K.
    Weber, Jeffrey S.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [39] The tumor suppressor menin prevents effector CD8 T-cell dysfunction by targeting mTORC1-dependent metabolic activation
    Junpei Suzuki
    Takeshi Yamada
    Kazuki Inoue
    Shogo Nabe
    Makoto Kuwahara
    Nobuaki Takemori
    Ayako Takemori
    Seiji Matsuda
    Makoto Kanoh
    Yuuki Imai
    Masaki Yasukawa
    Masakatsu Yamashita
    Nature Communications, 9
  • [40] An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
    Sainson, Richard C. A.
    Thotakura, Anil K.
    Kosmac, Miha
    Borhis, Gwenoline
    Parveen, Nahida
    Kimber, Rachael
    Carvalho, Joana
    Henderson, Simon J.
    Pryke, Kerstin L.
    Okell, Tracey
    O'Leary, Siobhan
    Ball, Stuart
    Van Krinks, Cassie
    Gamand, Lauriane
    Taggart, Emma
    Pring, Eleanor J.
    Ali, Hanif
    Craig, Hannah
    Wong, Vivian W. Y.
    Liang, Qi
    Rowlands, Robert J.
    Lecointre, Morgane
    Campbell, Jamie
    Kirby, Ian
    Melvin, David
    Germaschewski, Volker
    Oelmann, Elisabeth
    Quaratino, Sonia
    McCourt, Matthew
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (12) : 1568 - 1582
12345